Table 1A.
Laboratory Data on Admission.
| WBC | 3,990 | /μL | PG | 639 | mg/dL | |||
| (Neutro 73.4%, Eos 0.5 %, Lym 15%) | HbA1c | 7.7 | % | |||||
| Hb | 12.8 | g/dL | Glucagon | 173 | pg/mL | (71-174) | ||
| Plt | 8.6 | ×104/μL | Fasting C-peptide | <0.01 | ng/mL | (0.9-3.8) | ||
| AST | 21 | IU/L | Anti-GAD antibody | <5.0 | U/mL | (<5.0) | ||
| ALT | 20 | IU/L | Anti-IA2 antibody | <0.4 | U/mL | (<0.4) | ||
| γ-GTP | 26 | IU/L | Anti-insulin Ab | 1.8 | % | (<0.4) | ||
| ALP | 377 | IU/L | ||||||
| BUN | 24 | mg/dL | ANA | ×320, speckled | (<40) | |||
| Cr | 0.77 | mg/dL | C3 | 95 | mg/dL | (65-135) | ||
| T-bil | 1.4 | mg/dL | C4 | 23 | mg/dL | (13-35) | ||
| Na | 129 | mEq/L | CH50 | 50.0 | U/mL | (30-50) | ||
| K | 5.0 | mEq/L | KL-6 | 514 | U/mL | (<500) | ||
| Cl | 95 | mEq/L | SP-A | 26.4 | ng/mL | (<43.8) | ||
| AMY | 47 | IU/L | (40-122) | SP-D | 73.5 | ng/mL | (<110) | |
| CRP | 0.07 | mg/dL | (<0.30) | sIL2R | 1,125 | U/mL | (145-519) | |
| Urinary analysis | Arterial blood gas analysis | |||||||
| Protein | (-) | pH | 7.432 | |||||
| Occult blood | (-) | pCO2 | 35.4 | mmHg | ||||
| Sugar | (4+) | pO2 | 84.7 | mmHg | ||||
| Ketone | (1+) | HCO3 | 23.2 | mmol/L | ||||
Footnote: underline denote abnormal values.
ANA: anti-nuclear antibody, sIL2R: serum soluble interleukin-2